Home / BIOVF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does BIOVF make money? Does BIOVF have pricing power? What's the Earnings Whisper? Will BIOVF profit more as the business scales? What is BIOVF's management track record? Is BIOVF's current price justified?

Swedish Orphan Biovitrum AB (publ)

$48.13 +$12.88 (+36.53%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$48.13

Day Range

$47.35$48.13

Year Range

$29.18$49.03

Market Cap

16.71B

AVG Volume

Trailing/Forward PE

110.43/2.06

PEG ratio

4.4

Dividend Yield

Next Earnings Date

2026-10-27

Primary Exchange

Other OTC

Revenue (SEK)

BIOVF Revenue (SEK) by year
Period	Revenue (SEK)
2025	28.16B
2024	26.03B
2023	22.12B
2022	18.79B
2021	15.53B
2020	15.26B
2019	14.25B
2018	9.14B
2017	6.51B
2016	5.2B

Net Income (SEK)

BIOVF Net Income (SEK) by year
Period	Net Income (SEK)
2025	493.33M
2024	3.88B
2023	2.41B
2022	2.64B
2021	2.68B
2020	3.25B
2019	3.3B
2018	2.42B
2017	1.12B
2016	808.07M

Operating Income (SEK)

BIOVF Operating Income (SEK) by year
Period	Operating Income (SEK)
2025	7.54B
2024	5.62B
2023	4.07B
2022	3.71B
2021	3.73B
2020	4.82B
2019	4.53B
2018	3.12B
2017	1.6B
2016	1.13B

EBITDA (SEK)

BIOVF EBITDA (SEK) by year
Period	EBITDA (SEK)
2025	11.29B
2024	9.49B
2023	7.3B
2022	6.73B
2021	5.62B
2020	6.69B
2019	6.02B
2018	3.62B
2017	2.08B
2016	1.57B

Cash Flows (SEK)

BIOVF Cash Flows (SEK) by year
Period	Cash Flows (SEK)
2025	8.1B
2024	4.55B
2023	-474M
2022	3.1B
2021	5.1B
2020	1.36B
2019	-6.11B
2018	1.51B
2017	1.2B
2016	51.39M

EPS (SEK)

BIOVF EPS (SEK) by year
Period	EPS (SEK)
2025	1.34
2024	11.23
2023	7.58
2022	8.64
2021	9.01
2020	10.9
2019	11.23
2018	8.94
2017	4.16
2016	3

Expenses (SEK)

BIOVF Expenses (SEK) by year
Period	Expenses (SEK)
2025	5.7B
2024	15.03B
2023	15.12B
2022	11.16B
2021	8.2B
2020	10.95B
2019	15.82B
2018	4.18B
2017	3.14B
2016	2.72B

Cash & Debt (SEK)

BIOVF Cash & Debt (SEK) by year
Period	Cash & Debt (SEK)
2025	1.04B
2024	1.14B
2023	904M
2022	1.36B
2021	1.04B
2020	404M
2019	737M
2018	3B
2017	1.48B
2016	785.79M

Debt ratios

BIOVF Debt ratios by year
Period	Debt ratios
2025	0.3
2024	0.54
2023	0.74
2022	0.31
2021	0.45
2020	0.77
2019	1.19
2018	-0.39

Margins

BIOVF Margins by year
Period	Margins
2025	49.52%
2024	74.53%
2023	72.92%
2022	74.05%
2021	77.56%
2020	78.86%
2019	76.59%
2018	73.57%
2017	71.52%
2016	70.14%

Return on Capital

BIOVF Return on Capital by year
Period	Return on Capital
2025	1.31%
2024	9.64%
2023	7.11%
2022	9.95%
2021	11.54%
2020	16.06%
2019	19.52%
2018	26.75%
2017	16.77%
2016	15.09%

Shares Outstanding

BIOVF Shares Outstanding by year
Period	Shares Outstanding
2025	345.34M
2024	343.23M
2023	339.57M
2022	309.89M
2021	295.05M
2020	294.66M
2019	292.65M
2018	269.52M
2017	269.91M
2016	268.36M

Book Value Per Share (SEK)

BIOVF Book Value Per Share (SEK) by year
Period	Book Value Per Share (SEK)
2025	108.96
2024	117.4
2023	99.73
2022	85.6
2021	78.64
2020	68.57
2019	57.85
2018	33.54
2017	24.82
2016	19.95

Total Assets (SEK)

BIOVF Total Assets (SEK) by year
Period	Total Assets (SEK)
2025	67.28B
2024	75.44B
2023	74.03B
2022	52.62B
2021	48.72B
2020	48.28B
2019	45.66B
2018	17.18B
2017	10.9B
2016	9.97B

PE Ratio

BIOVF PE Ratio by year
Period	PE Ratio
Sep 26	172.37
Sep 26	169.79
Aug 26	170.81
Aug 26	168.41
Aug 26	169.4
Aug 26	168.57
Jul 26	169.04
Jul 26	175.67
Jul 26	174.56
Jul 26	174.84
Jul 26	171.21
Jun 26	326.7
Jun 26	321.97
Jun 26	316.31
Jun 26	318
May 26	306.76
May 26	311.13
May 26	313.61
May 26	305.91
May 26	304.97
Apr 26	256.94
Apr 26	255.43
Apr 26	258.37
Apr 26	262.83
Mar 26	4085.54
Mar 26	4027.46
Mar 26	4088.46
Mar 26	3952.48
Feb 26	3480.6
Feb 26	3495.32
Feb 26	3442.78
Feb 26	3483.39
Jan 26	3438.24
Jan 26	3449.65
Jan 26	3561.07
Jan 26	3515.16
Jan 26	3387.46
Dec 25	25.35
Dec 25	25.67
Dec 25	25.65
Dec 25	26.02
Nov 25	25.85
Nov 25	26.13
Nov 25	25.9
Nov 25	26.07
Oct 25	24.79
Oct 25	24.55
Oct 25	24.67
Oct 25	24.85
Oct 25	22.09
Sep 25	24.49
Sep 25	24.52
Sep 25	23.58
Sep 25	23.74
Aug 25	25.04
Aug 25	25.29
Aug 25	23.98
Aug 25	24.72
Aug 25	24.88
Jul 25	24.55
Jul 25	24.94
Jul 25	24.22
Jul 25	24.28
Jun 25	24.48
Jun 25	23.08
Jun 25	26.75
Jun 25	25.77
May 25	25.62
May 25	25.45
May 25	26.28
May 25	26.13
May 25	25.99
Apr 25	24.8
Apr 25	22.93
Apr 25	22.47
Apr 25	25.31
Mar 25	28.01
Mar 25	28.39
Mar 25	29.62
Mar 25	29.51
Feb 25	31.19
Feb 25	31.61
Feb 25	31.76
Feb 25	32.53
Jan 25	33.01
Jan 25	30.14
Jan 25	30.89
Jan 25	30.94
Jan 25	30.64
Dec 24	48.28
Dec 24	50.09
Dec 24	49.82
Dec 24	48.47
Nov 24	47.07
Nov 24	49.56
Nov 24	54.63
Nov 24	53.91
Nov 24	54.62
Oct 24	53.98
Oct 24	49.22

Free Cash Flow Yield

BIOVF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	4.14%
Sep 26	4.21%
Aug 26	4.18%
Aug 26	4.24%
Aug 26	4.22%
Aug 26	4.24%
Jul 26	4.22%
Jul 26	4.07%
Jul 26	4.09%
Jul 26	4.08%
Jul 26	4.17%
Jun 26	5.02%
Jun 26	5.1%
Jun 26	5.19%
Jun 26	5.16%
May 26	5.35%
May 26	5.28%
May 26	5.23%
May 26	5.37%
May 26	5.38%
Apr 26	6.39%
Apr 26	6.43%
Apr 26	6.35%
Apr 26	6.25%
Mar 26	5.09%
Mar 26	5.17%
Mar 26	5.09%
Mar 26	5.26%
Feb 26	5.98%
Feb 26	5.95%
Feb 26	6.04%
Feb 26	5.97%
Jan 26	6.05%
Jan 26	6.03%
Jan 26	5.84%
Jan 26	5.92%
Jan 26	6.14%
Dec 25	3.67%
Dec 25	3.62%
Dec 25	3.63%
Dec 25	3.58%
Nov 25	3.6%
Nov 25	3.56%
Nov 25	3.59%
Nov 25	3.57%
Oct 25	3.75%
Oct 25	3.79%
Oct 25	3.77%
Oct 25	3.75%
Oct 25	4.21%
Sep 25	5.49%
Sep 25	5.49%
Sep 25	5.71%
Sep 25	5.67%
Aug 25	5.37%
Aug 25	5.32%
Aug 25	5.61%
Aug 25	5.44%
Aug 25	5.41%
Jul 25	5.48%
Jul 25	5.39%
Jul 25	5.56%
Jul 25	5.54%
Jun 25	4.79%
Jun 25	5.08%
Jun 25	4.38%
Jun 25	4.55%
May 25	4.58%
May 25	4.61%
May 25	4.46%
May 25	4.49%
May 25	4.51%
Apr 25	4.73%
Apr 25	5.11%
Apr 25	5.22%
Apr 25	4.63%
Mar 25	3.49%
Mar 25	3.44%
Mar 25	3.3%
Mar 25	3.31%
Feb 25	3.13%
Feb 25	3.09%
Feb 25	3.08%
Feb 25	3%
Jan 25	2.96%
Jan 25	3.24%
Jan 25	3.16%
Jan 25	3.16%
Jan 25	3.19%
Dec 24	4.89%
Dec 24	4.71%
Dec 24	4.73%
Dec 24	4.87%
Nov 24	5.01%
Nov 24	4.76%
Nov 24	4.32%
Nov 24	4.38%
Nov 24	4.32%
Oct 24	4.37%
Oct 24	4.79%

Price to Sales

BIOVF Price to Sales by year
Period	Price to Sales
Sep 26	5.59
Sep 26	5.5
Aug 26	5.54
Aug 26	5.46
Aug 26	5.49
Aug 26	5.46
Jul 26	5.48
Jul 26	5.7
Jul 26	5.66
Jul 26	5.67
Jul 26	5.55
Jun 26	5.72
Jun 26	5.64
Jun 26	5.54
Jun 26	5.57
May 26	5.37
May 26	5.45
May 26	5.49
May 26	5.36
May 26	5.34
Apr 26	4.5
Apr 26	4.47
Apr 26	4.53
Apr 26	4.6
Mar 26	4.85
Mar 26	4.78
Mar 26	4.85
Mar 26	4.69
Feb 26	4.13
Feb 26	4.15
Feb 26	4.09
Feb 26	4.14
Jan 26	4.08
Jan 26	4.1
Jan 26	4.23
Jan 26	4.17
Jan 26	4.02
Dec 25	4.11
Dec 25	4.16
Dec 25	4.16
Dec 25	4.22
Nov 25	4.19
Nov 25	4.24
Nov 25	4.2
Nov 25	4.23
Oct 25	4.02
Oct 25	3.98
Oct 25	4
Oct 25	4.03
Oct 25	3.58
Sep 25	3.7
Sep 25	3.7
Sep 25	3.56
Sep 25	3.58
Aug 25	3.78
Aug 25	3.82
Aug 25	3.62
Aug 25	3.73
Aug 25	3.76
Jul 25	3.71
Jul 25	3.76
Jul 25	3.66
Jul 25	3.66
Jun 25	3.65
Jun 25	3.45
Jun 25	3.99
Jun 25	3.85
May 25	3.82
May 25	3.8
May 25	3.92
May 25	3.9
May 25	3.88
Apr 25	3.7
Apr 25	3.42
Apr 25	3.35
Apr 25	3.78
Mar 25	3.87
Mar 25	3.92
Mar 25	4.09
Mar 25	4.08
Feb 25	4.31
Feb 25	4.37
Feb 25	4.39
Feb 25	4.49
Jan 25	4.56
Jan 25	4.16
Jan 25	4.27
Jan 25	4.27
Jan 25	4.23
Dec 24	4.36
Dec 24	4.53
Dec 24	4.5
Dec 24	4.38
Nov 24	4.25
Nov 24	4.48
Nov 24	4.94
Nov 24	4.87
Nov 24	4.94
Oct 24	4.88
Oct 24	4.45

EV/EBITDA

BIOVF EV/EBITDA by year
Period	EV/EBITDA
Sep 26	15.54
Sep 26	15.33
Aug 26	15.42
Aug 26	15.22
Aug 26	15.3
Aug 26	15.24
Jul 26	15.27
Jul 26	15.81
Jul 26	15.72
Jul 26	15.74
Jul 26	15.45
Jun 26	15.21
Jun 26	15
Jun 26	14.75
Jun 26	14.83
May 26	14.33
May 26	14.53
May 26	14.63
May 26	14.3
May 26	14.26
Apr 26	12.16
Apr 26	12.09
Apr 26	12.22
Apr 26	12.41
Mar 26	13.7
Mar 26	13.53
Mar 26	13.71
Mar 26	13.3
Feb 26	11.85
Feb 26	11.89
Feb 26	11.73
Feb 26	11.85
Jan 26	11.72
Jan 26	11.75
Jan 26	12.09
Jan 26	11.95
Jan 26	11.56
Dec 25	12.16
Dec 25	12.3
Dec 25	12.29
Dec 25	12.45
Nov 25	12.38
Nov 25	12.5
Nov 25	12.4
Nov 25	12.48
Oct 25	11.92
Oct 25	11.82
Oct 25	11.87
Oct 25	11.95
Oct 25	10.75
Sep 25	11.58
Sep 25	11.59
Sep 25	11.2
Sep 25	11.26
Aug 25	11.81
Aug 25	11.91
Aug 25	11.37
Aug 25	11.67
Aug 25	11.74
Jul 25	11.6
Jul 25	11.77
Jul 25	11.46
Jul 25	11.49
Jun 25	11.66
Jun 25	11.09
Jun 25	12.59
Jun 25	12.19
May 25	12.13
May 25	12.06
May 25	12.4
May 25	12.34
May 25	12.28
Apr 25	11.79
Apr 25	11.03
Apr 25	10.84
Apr 25	12
Mar 25	12.17
Mar 25	12.31
Mar 25	12.77
Mar 25	12.73
Feb 25	13.35
Feb 25	13.5
Feb 25	13.56
Feb 25	13.84
Jan 25	14.02
Jan 25	12.96
Jan 25	13.24
Jan 25	13.26
Jan 25	13.15
Dec 24	14.93
Dec 24	15.41
Dec 24	15.34
Dec 24	14.98
Nov 24	14.6
Nov 24	15.27
Nov 24	16.62
Nov 24	16.43
Nov 24	16.62
Oct 24	16.45
Oct 24	15.18

Price/Operating Cashflow

BIOVF Price/Operating Cashflow by year
Period	Price/Operating Cashflow
Sep 26	21.89
Sep 26	21.56
Aug 26	21.69
Aug 26	21.38
Aug 26	21.51
Aug 26	21.4
Jul 26	21.46
Jul 26	22.3
Jul 26	22.16
Jul 26	22.2
Jul 26	21.74
Jun 26	18.86
Jun 26	18.59
Jun 26	18.26
Jun 26	18.36
May 26	17.71
May 26	17.97
May 26	18.11
May 26	17.66
May 26	17.61
Apr 26	14.84
Apr 26	14.75
Apr 26	14.92
Apr 26	15.18
Mar 26	18.3
Mar 26	18.04
Mar 26	18.31
Mar 26	17.7
Feb 26	15.59
Feb 26	15.65
Feb 26	15.42
Feb 26	15.6
Jan 26	15.4
Jan 26	15.45
Jan 26	15.95
Jan 26	15.74
Jan 26	15.17
Dec 25	16.44
Dec 25	16.65
Dec 25	16.63
Dec 25	16.87
Nov 25	16.76
Nov 25	16.95
Nov 25	16.8
Nov 25	16.91
Oct 25	16.08
Oct 25	15.92
Oct 25	16
Oct 25	16.11
Oct 25	14.33
Sep 25	12.72
Sep 25	12.74
Sep 25	12.25
Sep 25	12.33
Aug 25	13.01
Aug 25	13.14
Aug 25	12.46
Aug 25	12.84
Aug 25	12.93
Jul 25	12.75
Jul 25	12.96
Jul 25	12.58
Jul 25	12.61
Jun 25	12.54
Jun 25	11.82
Jun 25	13.7
Jun 25	13.2
May 25	13.12
May 25	13.04
May 25	13.46
May 25	13.38
May 25	13.31
Apr 25	12.7
Apr 25	11.75
Apr 25	11.51
Apr 25	12.97
Mar 25	14.35
Mar 25	14.54
Mar 25	15.17
Mar 25	15.11
Feb 25	15.98
Feb 25	16.19
Feb 25	16.27
Feb 25	16.66
Jan 25	16.91
Jan 25	15.43
Jan 25	15.82
Jan 25	15.85
Jan 25	15.7
Dec 24	15.41
Dec 24	15.99
Dec 24	15.9
Dec 24	15.47
Nov 24	15.02
Nov 24	15.82
Nov 24	17.44
Nov 24	17.2
Nov 24	17.43
Oct 24	17.23
Oct 24	15.71

Price to Book

BIOVF Price to Book by year
Period	Price to Book
Sep 26	4
Sep 26	3.94
Aug 26	3.96
Aug 26	3.9
Aug 26	3.93
Aug 26	3.91
Jul 26	3.92
Jul 26	4.07
Jul 26	4.05
Jul 26	4.05
Jul 26	3.97
Jun 26	4.28
Jun 26	4.22
Jun 26	4.15
Jun 26	4.17
May 26	4.02
May 26	4.08
May 26	4.11
May 26	4.01
May 26	4
Apr 26	3.37
Apr 26	3.35
Apr 26	3.39
Apr 26	3.45
Mar 26	3.77
Mar 26	3.72
Mar 26	3.78
Mar 26	3.65
Feb 26	3.21
Feb 26	3.23
Feb 26	3.18
Feb 26	3.22
Jan 26	3.18
Jan 26	3.19
Jan 26	3.29
Jan 26	3.25
Jan 26	3.13
Dec 25	2.84
Dec 25	2.87
Dec 25	2.87
Dec 25	2.91
Nov 25	2.89
Nov 25	2.92
Nov 25	2.9
Nov 25	2.92
Oct 25	2.77
Oct 25	2.75
Oct 25	2.76
Oct 25	2.78
Oct 25	2.47
Sep 25	2.48
Sep 25	2.49
Sep 25	2.39
Sep 25	2.41
Aug 25	2.54
Aug 25	2.57
Aug 25	2.43
Aug 25	2.51
Aug 25	2.52
Jul 25	2.49
Jul 25	2.53
Jul 25	2.46
Jul 25	2.46
Jun 25	2.36
Jun 25	2.23
Jun 25	2.58
Jun 25	2.48
May 25	2.47
May 25	2.45
May 25	2.53
May 25	2.52
May 25	2.51
Apr 25	2.39
Apr 25	2.21
Apr 25	2.17
Apr 25	2.44
Mar 25	2.65
Mar 25	2.69
Mar 25	2.8
Mar 25	2.79
Feb 25	2.95
Feb 25	2.99
Feb 25	3.01
Feb 25	3.08
Jan 25	3.12
Jan 25	2.85
Jan 25	2.92
Jan 25	2.93
Jan 25	2.9
Dec 24	2.83
Dec 24	2.94
Dec 24	2.92
Dec 24	2.84
Nov 24	2.76
Nov 24	2.91
Nov 24	3.21
Nov 24	3.16
Nov 24	3.21
Oct 24	3.17
Oct 24	2.89

No video analysis for this stock yet. Request one from our team.

News: BIOVF

defenseworld.net · 15 Aug 2026

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) Short Interest Update

Swedish Orphan Biovitrum (OTCMKTS:BIOVF - Get Free Report) was the target of a significant growth in short interest in July. As of July 31st, there was short interest totaling 649,723 shares, a growth of 139.7% from the July 15th total of 271,067 shares. Currently, 0.2% of the shares of the stock are sold short. Based

AI Analysis

Swedish Orphan Biovitrum AB (publ)

Video analysis: BIOVF

News: BIOVF

Swedish Orphan Biovitrum (OTCMKTS:BIOVF) Short Interest Update

Similar companies